(19)
(11) EP 3 695 013 A1

(12)

(43) Date of publication:
19.08.2020 Bulletin 2020/34

(21) Application number: 18762493.7

(22) Date of filing: 29.08.2018
(51) International Patent Classification (IPC): 
C12Q 1/6886(2018.01)
C07K 16/30(2006.01)
 C07K 16/28(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/EP2018/073243
(87) International publication number:
WO 2019/043059 (07.03.2019 Gazette 2019/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 30.08.2017 US 201762552125 P

(71) Applicant: Symphogen A/S
2750 Ballerup (DK)

(72) Inventors:
  • KRAGH, Michael
    2750 Ballerup (DK)
  • POULSEN, Thomas Tuxen
    2750 Ballerup (DK)
  • DING, Cliff
    2750 Ballerup (DK)
  • HORAK, Ivan David
    2750 Ballerup (DK)

(74) Representative: Pohlman, Sandra M. 
df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16
80333 München
80333 München (DE)

   


(54) COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-EGFR ANTIBODIES